Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

Table of Contents

January 1, 2021; Volume 62,Issue 1

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 12A;

Editor’s Page

  • You have access
    Humana and 18F-FDG PET/CT: Another Sequel to the Injustice of Being Judged by the Errors of Others
    Johannes Czernin and Andrei Iagaru
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 1-2;

Discussions with Leaders

  • You have access
    Irène Buvat and Ken Herrmann Talk with Alexander Stremitzer, Kevin Tobia, and Aileen Nielsen
    Irène Buvat, Ken Herrmann, Alexander Stremitzer, Kevin Tobia and Aileen Nielsen
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 3-5; DOI: https://doi.org/10.2967/jnumed.120.260505

The State of the Art

  • You have access
    Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy
    Richard L. Wahl, Panithaya Chareonthaitawee, Bonnie Clarke, Alexander Drzezga, Liza Lindenberg, Arman Rahmim, James Thackeray, Gary A. Ulaner, Wolfgang Weber, Katherine Zukotynski and John Sunderland
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 6-14; DOI: https://doi.org/10.2967/jnumed.120.253450

Artificial Intelligence

  • INVITED PERSPECTIVE

    • You have access
      How Much Can Potential Jurors Tell Us About Liability for Medical Artificial Intelligence?
      W. Nicholson Price, Sara Gerke and I. Glenn Cohen
      Journal of Nuclear Medicine January 1, 2021, 62 (1) 15-16; DOI: https://doi.org/10.2967/jnumed.120.257196
  • Open Access
    When Does Physician Use of AI Increase Liability?
    Kevin Tobia, Aileen Nielsen and Alexander Stremitzer
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 17-21; DOI: https://doi.org/10.2967/jnumed.120.256032

Continuing Education

  • You have access
    Machine Learning in Nuclear Medicine: Part 2—Neural Networks and Clinical Aspects
    Katherine Zukotynski, Vincent Gaudet, Carlos F. Uribe, Sulantha Mathotaarachchi, Kenneth C. Smith, Pedro Rosa-Neto, François Bénard and Sandra E. Black
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 22-29; DOI: https://doi.org/10.2967/jnumed.119.231837

Oncology

  • Clinical

    • Deep-Learning <sup>18</sup>F-FDG Uptake Classification Enables Total Metabolic Tumor Volume Estimation in Diffuse Large B-Cell Lymphoma
      Open Access
      Deep-Learning 18F-FDG Uptake Classification Enables Total Metabolic Tumor Volume Estimation in Diffuse Large B-Cell Lymphoma
      Nicolò Capobianco, Michel Meignan, Anne-Ségolène Cottereau, Laetitia Vercellino, Ludovic Sibille, Bruce Spottiswoode, Sven Zuehlsdorff, Olivier Casasnovas, Catherine Thieblemont and Irène Buvat
      Journal of Nuclear Medicine January 1, 2021, 62 (1) 30-36; DOI: https://doi.org/10.2967/jnumed.120.242412
    • You have access
      Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUVmax Method
      Jan Rekowski, Andreas Hüttmann, Christine Schmitz, Stefan P. Müller, Lars Kurch, Jörg Kotzerke, Christiane Franzius, Matthias Weckesser, Frank M. Bengel, Martin Freesmeyer, Andreas Hertel, Thomas Krohn, Jens Holzinger, Ingo Brink, Uwe Haberkorn, Fonyuy Nyuyki, Daniëlle M.E. van Assema, Lilli Geworski, Dirk Hasenclever, Karl-Heinz Jöckel and Ulrich Dührsen
      Journal of Nuclear Medicine January 1, 2021, 62 (1) 37-42; DOI: https://doi.org/10.2967/jnumed.120.244145
    • <sup>124</sup>I-MIBG PET/CT to Monitor Metastatic Disease in Children with Relapsed Neuroblastoma
      You have access
      124I-MIBG PET/CT to Monitor Metastatic Disease in Children with Relapsed Neuroblastoma
      Mariam S. Aboian, Shih-ying Huang, Miguel Hernandez-Pampaloni, Randall A. Hawkins, Henry F. VanBrocklin, Yoonsuk Huh, Kieuhoa T. Vo, W. Clay Gustafson, Katherine K. Matthay and Youngho Seo
      Journal of Nuclear Medicine January 1, 2021, 62 (1) 43-47; DOI: https://doi.org/10.2967/jnumed.120.243139
    • The Prognostic Value of Quantitative Bone SPECT/CT Before <sup>223</sup>Ra Treatment in Metastatic Castration-Resistant Prostate Cancer
      You have access
      The Prognostic Value of Quantitative Bone SPECT/CT Before 223Ra Treatment in Metastatic Castration-Resistant Prostate Cancer
      Helmut Dittmann, Sabine Kaltenbach, Matthias Weissinger, Francesco Fiz, Peter Martus, Maren Pritzkow, Juergen Kupferschlaeger and Christian la Fougère
      Journal of Nuclear Medicine January 1, 2021, 62 (1) 48-54; DOI: https://doi.org/10.2967/jnumed.119.240408
  • Basic

    • TAG-72–Targeted α-Radionuclide Therapy of Ovarian Cancer Using <sup>225</sup>Ac-Labeled DOTAylated-huCC49 Antibody
      You have access
      TAG-72–Targeted α-Radionuclide Therapy of Ovarian Cancer Using 225Ac-Labeled DOTAylated-huCC49 Antibody
      Megan Minnix, Lin Li, Paul J. Yazaki, Aaron D. Miller, Junie Chea, Erasmus Poku, An Liu, Jeffrey Y.C. Wong, Russell C. Rockne, David Colcher and John E. Shively
      Journal of Nuclear Medicine January 1, 2021, 62 (1) 55-61; DOI: https://doi.org/10.2967/jnumed.120.243394

Theranostics

  • Clinical

    • You have access
      Unexplained Hyperthyroglobulinemia in Differentiated Thyroid Cancer Patients as an Indication for Radioiodine Adjuvant Therapy: A Prospective Multicenter Study
      Lin Cheng, Ri Sa, Qiong Luo, Hao Fu, Yuchen Jin, Linglin Tang, Yi Yang, Chunjing Yu and Libo Chen
      Journal of Nuclear Medicine January 1, 2021, 62 (1) 62-68; DOI: https://doi.org/10.2967/jnumed.120.243642
    • You have access
      Risk of Bowel Obstruction in Patients with Mesenteric or Peritoneal Disease Receiving Peptide Receptor Radionuclide Therapy
      Jonathan R. Strosberg, Taymeyah Al-Toubah, Eleonora Pellè, Johnna Smith, Mintallah Haider, Tai Hutchinson, Jason B. Fleming and Ghassan El-Haddad
      Journal of Nuclear Medicine January 1, 2021, 62 (1) 69-72; DOI: https://doi.org/10.2967/jnumed.120.242875
    • FEATURED ARTICLE OF THE MONTH

      • You have access
        64Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours After Injection
        Mathias Loft, Esben A. Carlsen, Camilla B. Johnbeck, Helle H. Johannesen, Tina Binderup, Andreas Pfeifer, Jann Mortensen, Peter Oturai, Annika Loft, Anne K. Berthelsen, Seppo W. Langer, Ulrich Knigge and Andreas Kjaer
        Journal of Nuclear Medicine January 1, 2021, 62 (1) 73-80; DOI: https://doi.org/10.2967/jnumed.120.244509
    • You have access
      The Effects of Monosodium Glutamate on PSMA Radiotracer Uptake in Men with Recurrent Prostate Cancer: A Prospective, Randomized, Double-Blind, Placebo-Controlled Intraindividual Imaging Study
      Sara Harsini, Heather Saprunoff, Tina Alden, Behnoud Mohammadi, Don Wilson and François Bénard
      Journal of Nuclear Medicine January 1, 2021, 62 (1) 81-87; DOI: https://doi.org/10.2967/jnumed.120.246983
    • BRIEF COMMUNICATION

      • PSMA-Ligand PET for Early Castration-Resistant Prostate Cancer: A Retrospective Single-Center Study
        You have access
        PSMA-Ligand PET for Early Castration-Resistant Prostate Cancer: A Retrospective Single-Center Study
        Manuel Weber, Claudia Kurek, Francesco Barbato, Matthias Eiber, Tobias Maurer, Michael Nader, Boris Hadaschik, Viktor Grünwald, Ken Herrmann, Axel Wetter and Wolfgang P. Fendler
        Journal of Nuclear Medicine January 1, 2021, 62 (1) 88-91; DOI: https://doi.org/10.2967/jnumed.120.245456
  • Basic

    • You have access
      Effect of Tumor Perfusion and Receptor Density on Tumor Control Probability in 177Lu-DOTATATE Therapy: An In Silico Analysis for Standard and Optimized Treatment
      Luis David Jiménez-Franco, Gerhard Glatting, Vikas Prasad, Wolfgang A. Weber, Ambros J. Beer and Peter Kletting
      Journal of Nuclear Medicine January 1, 2021, 62 (1) 92-98; DOI: https://doi.org/10.2967/jnumed.120.245068

Pediatrics

  • Clinical

    • PROCEDURE STANDARD

      • Open Access
        SNMMI Procedure Standard/EANM Practice Guideline on Pediatric 18F-FDG PET/CT for Oncology 1.0
        Reza Vali, Adam Alessio, Rene Balza, Lise Borgwardt, Zvi Bar-Sever, Michael Czachowski, Nina Jehanno, Lars Kurch, Neeta Pandit-Taskar, Marguerite Parisi, Arnoldo Piccardo, Victor Seghers, Barry L. Shulkin, Pietro Zucchetta and Ruth Lim
        Journal of Nuclear Medicine January 1, 2021, 62 (1) 99-110; DOI: https://doi.org/10.2967/jnumed.120.254110

Cardiovascular

  • Basic

    • FEATURED BASIC SCIENCE ARTICLE

      • Targeted PET Imaging of Chemokine Receptor 2–Positive Monocytes and Macrophages in the Injured Heart
        You have access
        Targeted PET Imaging of Chemokine Receptor 2–Positive Monocytes and Macrophages in the Injured Heart
        Gyu Seong Heo, Geetika Bajpai, Wenjun Li, Hannah P. Luehmann, Deborah H. Sultan, Hao Dun, Florian Leuschner, Steven L. Brody, Robert J. Gropler, Daniel Kreisel, Kory J. Lavine and Yongjian Liu
        Journal of Nuclear Medicine January 1, 2021, 62 (1) 111-114; DOI: https://doi.org/10.2967/jnumed.120.244673

Gastroenterology

  • Clinical

    • You have access
      Experience with Esophagogastrointestinal Transit Scintigraphy in the Initial 229 Patients: Multiple Regions of Dysmotility Are Common
      Harvey A. Ziessman, Mathurika Jeyasingam, Ahsan U. Khan, Zsuzsanna McMahan and Pankaj J. Pasricha
      Journal of Nuclear Medicine January 1, 2021, 62 (1) 115-122; DOI: https://doi.org/10.2967/jnumed.120.243527

Physics and Instrumentation

  • You have access
    Investigating Low-Dose Image Quality in Whole-Body Pediatric 18F-FDG Scans Using Time-of-Flight PET/MRI
    Jeffrey P. Schmall, Suleman Surti, Hansel J. Otero, Sabah Servaes, Joel S. Karp and Lisa J. States
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 123-130; DOI: https://doi.org/10.2967/jnumed.119.240127

Radiochemistry

  • You have access
    Cyclotron Production and Separation of Scandium Radionuclides from Natural Titanium Metal and Titanium Dioxide Targets
    C. Shaun Loveless, Jose R. Blanco, George L. Diehl, Rawdah T. Elbahrawi, Tommaso S. Carzaniga, Saverio Braccini and Suzanne E. Lapi
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 131-136; DOI: https://doi.org/10.2967/jnumed.120.242941

Molecular Imaging

  • Basic

    • You have access
      Preclinical Evaluation of an Engineered Single-Chain Fragment Variable-Fragment Crystallizable Targeting Human CD44
      Philipp Diebolder, Cedric Mpoy, Jalen Scott, Truc T. Huynh, Ryan Fields, Dirk Spitzer, Nilantha Bandara and Buck E. Rogers
      Journal of Nuclear Medicine January 1, 2021, 62 (1) 137-143; DOI: https://doi.org/10.2967/jnumed.120.249557

Letters to the Editor

  • You have access
    Distribution Volume of 18F-BMS‐986192 in NSCLC Patients
    Eric Laffon and Roger Marthan
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 144; DOI: https://doi.org/10.2967/jnumed.120.248484

SNMMI Newsline

  • You have access
    SNMMI Newsline
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 13N-24N;
  • You have access
    SNMMI Diversity, Equity, and Inclusion Task Force Statement
    Hyewon Hyun and Alan Packard
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 13N;
  • You have access
    2020 SNMMI Highlights Lecture: Oncology and Therapy, Part 2
    Andrew M. Scott
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 14N-19N;
  • You have access
    Humana Decision to Deny PET/CT Coverage
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 20N;
  • You have access
    DOE Isotope Program Releases Annual Update on Medical Isotopes
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 21N;
  • You have access
    SNMMI Leadership Update: Improving Radionuclide Availability
    Alan B. Packard
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 22N;
  • You have access
    FDA Guidance on Clinical Trial Diversity
    Journal of Nuclear Medicine January 1, 2021, 62 (1) 23N-24N;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 62 (1)
Journal of Nuclear Medicine
Vol. 62, Issue 1
January 1, 2021
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • 64Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours After Injection
  • Targeted PET Imaging of Chemokine Receptor 2–Positive Monocytes and Macrophages in the Injured Heart
Sign up for alerts

Jump to

  • This Month in JNM
  • Editor’s Page
  • Discussions with Leaders
  • The State of the Art
  • Artificial Intelligence
    • INVITED PERSPECTIVE
  • Continuing Education
  • Oncology
    • Clinical
    • Basic
  • Theranostics
    • Clinical
      • FEATURED ARTICLE OF THE MONTH
      • BRIEF COMMUNICATION
    • Basic
  • Pediatrics
    • Clinical
      • PROCEDURE STANDARD
  • Cardiovascular
    • Basic
      • FEATURED BASIC SCIENCE ARTICLE
  • Gastroenterology
    • Clinical
  • Physics and Instrumentation
  • Radiochemistry
  • Molecular Imaging
    • Basic
  • Letters to the Editor
  • SNMMI Newsline
  • Most Cited
  • Most Read
Loading
  • Initial Clinical Experience with 90Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 Patients
  • Total-Body PET Multiparametric Imaging of Cancer Using a Voxelwise Strategy of Compartmental Modeling
  • Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohort
  • Why We Did What We Did: PSMA PET/CT Selection Criteria for the VISION Trial
  • 68Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the 68Ga-FAPI PET Prospective Observational Trial
More...
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire